Cara Therapeutics, Inc.

Cara Therapeutics, Inc.

0HTC.L
Cara Therapeutics, Inc.GB flagLondon Stock Exchange
15.99
USD
-0.79
- -
24.33MMarket Cap

Cara Therapeutics, Inc. (0HTC.L) Stock Split History

Learn about Cara Therapeutics, Inc.'s most recent 83333-for-1000000 basis stock split on December 31, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Cara Therapeutics, Inc.'s most recent stock split

Split Date: 2024-12-31
Split Ratio: 83333:1000000
Price Before Split: $0.34
Price After Split: $0.03

Developer API

Get 0HTC.L split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/0HTC.L

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 12.00 times fewer shares (a 83333:1000000 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Cara Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-12-3183333:1000000Yes$0.34$0.03

About Cara Therapeutics, Inc.

Company overview and industry information

Cara Therapeutics, Inc. (0HTC.L) operates in the Biotechnology industry. The recent 83333-for-1000000 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Cara Therapeutics, Inc. Summary

Last updated: 7/10/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.